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Abstract
Background: Radiofrequency	catheter	ablation	(RFCA)	for	accessory	pathways	(APs)	
at	the	site	of	prior	valve	surgery	(VS)	remains	challenging.	We	aimed	to	clarify	the	
factors	associated	with	successful	RFCA	for	such	APs.
Methods: Upon	 reviewing	 a	 RFCA	 registry	 and	 previous	 case	 reports,	 we	 in‐
cluded	nine	patients	who	underwent	RFCA	of	APs	at	the	site	of	prior	VS	(total‐VS	
group;	age,	34.0	[24.5‐45.0]	years;	men,	4/9)	and	196	patients	who	underwent	
RFCA	of	APs	with	no	history	of	VS	 (no‐VS	group;	 age,	 40.5	 [23.0‐54.0]	 years;	
men,	114/196).	Electrophysiological	 features,	procedural	details,	and	outcomes	
were examined.
Results: Accessory	pathway	exhibited	decremental	 conduction	 in	 four	of	nine	pa‐
tients	in	the	total‐VS	group.	The	number	of	RFCA	attempts	was	significantly	higher	
in	 the	 total‐VS	 group	 than	 in	 the	 no‐VS	 group	 (10.0	 [4.5‐14.5]	 vs	 2.0	 [1.0‐3.0];	
P	<	0.001).	In	four	patients	who	underwent	mitral	VS,	successful	RFCA	was	achieved	
using	the	transaortic	approach,	coronary	sinus	(CS)	approach,	or	bipolar	ablation.	In	
three	 patients	who	 underwent	 tricuspid	VS,	 successful	 RFCA	was	 achieved	 using	
the	above‐prosthetics	or	trans‐prosthetics	approach.	 In	two	patients,	RFCA	failed.	
The	trans‐prosthetics	approach	and	bipolar	ablation	technique	were	effective.	The	
transaortic	and	CS	approaches	were	occasionally	effective.	The	transseptal	approach	
was	ineffective.
Conclusions: Successful	RFCA	of	APs	at	the	site	of	prior	VS	can	be	achieved	by	de‐
tailed	mapping	of	the	areas	both	above	and	below	the	prosthetic	valve,	as	well	as	by	
ensuring	effective	radiofrequency	energy	delivery	using	various	catheter	approaches	
and	RFCA	techniques.
This	is	an	open	access	article	under	the	terms	of	the	Creat	ive	Commo	ns	Attri	butio	n‐NonCo	mmercial	License,	which	permits	use,	distribution	and	reproduction	
in	any	medium,	provided	the	original	work	is	properly	cited	and	is	not	used	for	commercial	purposes.
©	2019	The	Authors.	Journal of Arrhythmia	published	by	John	Wiley	&	Sons	Australia,	Ltd	on	behalf	of	the	Japanese	Heart	Rhythm	Society.
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1  | INTRODUC TION
Accessory	pathways	(APs)	can	be	arrhythmogenic	and	contribute	to	
a	reentry	circuit	of	atrioventricular	reentrant	tachycardia	(AVRT).	In	
most	cases,	APs	can	be	successfully	treated	by	radiofrequency	cath‐
eter	ablation	 (RFCA).	However,	 in	patients	with	valvular	heart	dis‐
ease,	RFCA	of	APs	is	challenging,	especially	if	the	AP	is	located	at	a	
valve	annulus	that	has	undergone	replacement	or	repair.	The	optimal	
strategy	for	RFCA	of	APs	at	the	site	of	prior	valve	surgery	(VS)	re‐
mains	unclear,	as	very	few	case	reports	on	this	have	been	published	
to date.1‒5	We	aimed	to	clarify	the	factors	associated	with	successful	
RFCA	for	such	APs.	In	this	context,	the	specific	goals	of	the	present	
study	 were:	 (a)	 to	 elucidate	 the	 electrophysiological	 features	 and	
RFCA	outcomes	of	APs	 at	 the	 site	of	 prior	VS;	 and	 (b)	 to	 identify	
useful	catheter	approaches	and	RFCA	techniques	for	successful	ab‐
lation	of	such	APs.
2  | METHODS
2.1 | Patients
The	study	design	was	approved	by	the	institutional	review	board	of	
our	hospital	(IRB	Number:	4‐2018‐0649).	The	study	was	conducted	
in	compliance	with	the	Declaration	of	Helsinki.	The	institutional	re‐
view	board	waived	the	need	for	informed	consent	of	the	patients	to	
be	included	in	the	analysis,	as	well	as	the	need	for	review	by	a	criti‐
cal	event	committee	because	this	was	a	retrospective	study	and	no	
patient	identification	data	are	presented.
The	study	included	a	group	of	patients	who	received	RFCA	for	
APs	located	at	an	annulus	previously	involved	in	mitral	or	tricuspid	
VS	(total‐VS	group,	based	on	registry	and	case	report	data),	as	well	
as	a	control	group	consisting	of	RFCA	recipients	with	structurally	
normal	heart	and	without	a	history	of	VS	(no‐VS	group)	(Figure	1).	
To	select	suitable	patients,	we	retrospectively	reviewed	the	RFCA	
registry	 data	 of	 patients	 (age	 ≥	 15	 years)	 with	 APs	 treated	 be‐
tween	 January	 2004	 and	 June	 2018	 at	 Severance	 Hospital	 or	
Asan	 Medical	 Center,	 which	 are	 large‐volume	 university	 hospi‐
tals	 in	Seoul,	Korea;	patients	who	received	RFCA	for	APs	at	 the	
site	 of	 previous	 VS	 were	 included	 in	 the	 registry‐VS	 subgroup.	
In	addition,	we	searched	 the	 literature	 for	case	 reports	describ‐
ing	 patients	who	 received	RFCA	 for	APs	 at	 the	 site	 of	 previous	
VS,1‒5	and	included	such	patients	in	the	historical‐VS	group	of	the	
total‐VS	group.	The	no‐VS	group	included	patients	with	structur‐
ally	 normal	 heart	 and	 without	 a	 history	 of	 VS,	 who	 underwent	
RFCA	for	APs	during	the	year	leading	up	to	the	study	in	the	same	
electrophysiological	laboratory	as	the	patients	in	the	registry‐VS	
subgroup.
2.2 | Electrophysiological studies
Complete	electrophysiological	data	were	only	available	for	the	pa‐
tients	included	in	the	RFCA	registry,	and	not	for	those	described	in	
the	case	reports.	Therefore,	we	only	analyzed	electrophysiological	
data	for	patients	in	the	RFCA	registry	(i.e.,	the	registry‐VS	group	
and	the	no‐VS	group),	and	described	the	protocol	followed	in	the	
centers	participating	in	the	RFCA	registry.	After	the	electrophysi‐
ological	catheters	were	positioned,	programmed	electrical	stimuli	
were	applied,	with	or	without	 isoproterenol	 infusion.	After	tach‐
yarrhythmia	 was	 induced,	 the	 mechanisms	 of	 tachycardia	 were	
elucidated	 using	 conventional	 differential	 pacing	 maneuvers.	 In	
patients	with	a	concealed	AP,	the	AP	potentials	were	mapped	dur‐
ing	ventricular	pacing	and	AVRT.	 In	patients	with	a	manifest	AP,	
the	AP	potentials	were	mapped	during	 sinus	 rhythm,	ventricular	
pacing,	 and	 AVRT.	 The	 precise	 AP	 location	 was	 confirmed,	 and	
RFCA	was	performed.	The	end	points	of	RFCA	were	no	evidence	
of	AP	and	no	inducibility	of	tachycardia.	Follow‐up	electrocardiog‐
raphy	(ECG)	was	performed	at	1	day,	1‐2	weeks,	and	3‐6	months	
after	RFCA.
2.3 | Data acquisition and statistical analyses
The	 medical	 records,	 operation	 records,	 echocardiographic	 re‐
ports,	electrophysiological	reports,	intracardiac	electrograms	and	
fluoroscopic	 images	 stored	 in	 the	RFCA	 registry	were	 reviewed.	
For	 patients	 in	 the	 historical‐VS	 group,	 we	 carefully	 reviewed	
all	 information	 included	 in	 the	 published	 case	 reports.1‒5 Major 
complications	 were	 defined	 as	 atrioventricular	 block;	 cardiac	
perforation	 or	 tamponade;	 stroke	 or	 transient	 ischemic	 attack;	
and	 vascular	 access	 complications	 such	 as	 hematoma,	 pseudoa‐
neurysm,	 and	 arteriovenous	 fistula	 that	 required	 transfusion	 or	
K E Y W O R D S
accessory	pathway,	catheter	ablation,	Ebstein	anomaly,	prosthetic	valve,	Wolff‐Parkinson‐
White	syndrome
F I G U R E  1  Flow	diagram	and	numbers	of	patients.	AP,	accessory	
pathway;	RFCA,	radiofrequency	catheter	ablation;	VS,	valve	
surgery
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surgical	 procedures.	 The	 baseline	 characteristics,	 electrophysi‐
ological	 features,	and	number	of	RFCA	attempts	were	compared	
between	 the	 total‐VS	 group	 and	 the	 no‐VS	 group.	 The	 catheter	
approaches	and	RFCA	techniques	used	in	the	total‐VS	group	were	
examined	 in	detail	 in	order	 to	clarify	 the	 technical	 requirements	
for	 RFCA	 success.	 Success,	 recurrence,	 and	 complication	 rates	
were	not	statistically	compared	between	the	two	groups	because	
publication	bias	could	not	be	excluded.
The	 results	 are	 expressed	 as	median	 (interquartile	 range)	 for	
continuous	 data	 and	 as	 frequency	 (percentage)	 for	 categorical	
data.	To	compare	the	clinical	parameters	between	the	two	groups,	
we	used	the	Mann‐Whitney	U	test	for	continuous	data	and	Fisher's	
exact	 test	 for	categorical	data,	as	all	datasets	were	nonnormally	
distributed.	A	P	value	<0.05	was	considered	to	indicate	statistical	
significance.	The	data	were	analyzed	using	the	Statistical	Package	
for	 the	Social	Sciences,	 version	24.0	 (IBM	Corporation,	Armonk,	
NY).
3  | RESULTS
3.1 | Baseline characteristics and outcomes  
(total‐VS group vs no‐VS group)
Upon	screening	the	RFCA	registry,	we	identified	4003	patients	who	
underwent	RFCA	for	APs	at	one	of	the	participating	centers	during	
the	study	period.	The	 registry‐VS	subgroup	 included	 four	patients	
(prevalence,	0.1%;	age,	37.0	[25.8‐47.5]	years;	men,	3/4)	who	under‐
went	 RFCA	 for	APs	 at	 the	 site	 of	 prior	VS	 and	were	 listed	 in	 the	
RFCA	 registry.	 The	 historical‐VS	 subgroup	 included	 five	 patients	
(age,	 32.0	 [20.5‐44.5]	 years;	men,	 1/5)	who	 underwent	 RFCA	 for	
APs	at	 the	 site	of	prior	VS	and	were	described	 in	previously	pub‐
lished	case	reports.1‒5	The	no‐VS	group	included	196	patients	(age,	
40.5	[23.0‐54.0]	years;	men,	114/196)	without	a	history	of	VS	who	
underwent	RFCA	for	APs	during	the	year	leading	up	to	the	study	at	
the	same	electrophysiological	laboratory	as	the	patients	in	the	RFCA	
registry.
Table	1	summarizes	the	baseline	characteristics,	electrophysio‐
logical	features,	and	RFCA	outcomes	of	the	patients	in	the	total‐VS	
and	no‐VS	groups.	 In	 the	 total‐VS	group,	mitral	valve	 replacement	
(MVR),	 mitral	 valve	 repair	 (MVr),	 and	 tricuspid	 valve	 replacement	
(TVR)	were	performed	in	five,	one,	and	three	patients,	respectively.	
Manifest	APs,	APs	with	decremental	conduction	property,	and	anti‐
dromic	AVRT	were	significantly	more	frequent	in	the	total‐VS	group	
than	 in	 the	no‐VS	group.	APs	with	 slow	and	decremental	 conduc‐
tion	were	 found	 in	all	 three	patients	who	had	undergone	TVR	 for	
Ebstein	anomaly,	as	well	as	one	patient	who	had	undergone	MVR.	
In	 the	 total‐VS	group,	 the	 rates	of	 acute	 success,	major	 complica‐
tions,	and	recurrence	were	77.8%,	0%,	and	0%,	respectively.	In	the	
registry‐VS	group,	the	success	rate	was	2/4	(50.0%).	The	number	of	
RFCA	attempts	was	significantly	higher	in	the	total‐VS	group	than	in	
the	no‐VS	group	(P	<	0.001).	There	were	no	significant	differences	
between	the	two	groups	regarding	age,	gender,	location	of	the	APs,	
or	duration	of	follow‐up.
3.2 | Catheter approaches and RFCA techniques 
used for APs at the site of prior mitral VS
Table	 2	 provides	 detailed	 information	 regarding	 the	 nine	 patients	
in	 the	 total‐VS	group,	 among	whom	six	had	previously	undergone	
MVR	or	MVr.	RFCA	of	APs	at	 the	 site	of	prior	mitral	VS	was	 suc‐
cessful	 in	four	patients	and	failed	in	two	patients.	Among	the	four	
patients	who	underwent	successful	RFCA	for	APs	at	the	site	of	prior	
mitral	VS,	 the	 transaortic	approach,	coronary	sinus	 (CS)	approach,	
and	 bipolar	 ablation	 technique	 using	 both	 the	 transaortic	 and	 CS	
approaches	 were	 used	 in	 two,	 one,	 and	 one	 patient,	 respectively	
TA B L E  1  Baseline	characteristics,	electrophysiological	features,	
and	radiofrequency	catheter	ablation	outcomes
Characteristics
Total‐VS group 
(n = 9)
No‐VS group 
(n = 196) P value
Age,	y 34.0 
(24.5‐45.0)
40.5 
(23.0‐54.0)
0.326
Male gender 4	(44.4) 114	(58.2) 0.499
Prior	VS
Mitral valve 
replacement
5	(55.6) —  
Mitral	valve	repair 1	(11.1) —  
Tricuspid	valve	
replacement
3	(33.3) —  
Manifest	AP 7	(77.8) 83	(42.3) 0.045
Location	of	the	AP
Left 5	(55.6) 114	(58.2) 0.499
Septal 1	(11.1) 46	(23.5) >0.999
Right 3	(33.3) 36	(18.4) 0.377
Decremental con‐
duction	property
4	(44.4) 3	(1.5) 0.001
Induced arrhythmia
Orthodromic 
AVRT
5	(55.6) 162	(82.7) 0.063
Antidromic	AVRT 3	(33.3) 2	(1.0) 0.010
Atrial	fibrillation 2	(22.2) 24	(12.2) >0.999
No	induction 0	(0) 8	(4.1) —a
Number	of	RFCA	
attempts
10.0	(4.5‐14.5) 2.0	(1.0‐3.0) <0.001
Acute	success 7	(77.8) 196	(100) —b
Major	complications 0	(0) 1	(0.5) —b
Recurrence 0	(0) 8	(4.1) —b
Follow‐up	period,	
mo
11.4	(3.4‐86.2) 38.8	(21.1‐55.1) 0.296
Data	are	shown	as	median	(interquartile	range)	or	frequency	
(percentage).
Abbreviations:	AP,	accessory	pathway;	AVRT,	atrioventricular	reentrant	
tachycardia;	RFCA,	radiofrequency	catheter	ablation;	VS,	valve	surgery.
aStatistical	comparison	could	not	be	performed	because	the	number	of	
patients	was	small.	
bStatistical	comparison	was	not	performed	because	publication	bias	
could	not	be	excluded.	
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(Table	2).	The	transseptal	approach	was	not	effective	in	any	of	the	
five	patients	who	underwent	RFCA	using	this	approach.	We	further	
provide	an	overview	of	these	five	cases.
A	 40‐year‐old	male	 patient	 (No.	 1)	 with	Wolff‐Parkinson‐White	
(WPW)	 syndrome	 had	 undergone	MVR	with	 a	 bileaflet	mechanical	
valve.	Surgical	cryoablation	for	left	posterior	AP	had	been	performed	
during	MVR.	 However,	 the	 AP	 recurred	 at	 8	months	 after	 surgical	
ablation.	 In	 a	 subsequent	 electrophysiological	 study,	 decremental	
conduction	property	was	observed	during	ventricular	pacing.	The	AP	
could	not	 be	 completely	 ablated	with	 an	 irrigated	 ablation	 catheter	
using	the	transseptal,	CS,	or	transaortic	approaches.	Finally,	RFCA	was	
successfully	performed	using	the	bipolar	ablation	technique	with	one	
ablation	catheter	placed	under	the	mechanical	valve	via	the	transaor‐
tic	approach	and	the	other	ablation	catheter	placed	in	the	CS	which	
served	as	a	dispersive	electrode	(Figure	2).	A	32‐year‐old	female	(No.	
2)	who	 had	 undergone	MVR	with	 a	 bileaflet	mechanical	 valve	 pre‐
sented	 supraventricular	 tachycardia.1	 An	 electrophysiological	 study	
revealed	 a	 concealed	 left	 posteroseptal	 AP	 without	 decremental	
conduction	property.	RFCA	using	 the	 transseptal	approach	was	not	
successful,	and	mapping	in	the	CS	showed	no	ideal	target	site.	Finally,	
RFCA	for	the	AP	was	successfully	performed	using	the	transaortic	ap‐
proach.	A	52‐year‐old	 female	 (No.	3)	with	asymptomatic	ventricular	
preexcitation	had	undergone	MVR	with	a	bileaflet	mechanical	valve.2 
At	5	years	after	MVR,	the	patient	developed	narrow	QRS	tachycardia.	
An	electrophysiological	study	revealed	a	manifest	left	lateral	AP	with‐
out	decremental	conduction	property.	RFCA	for	AP	was	successfully	
performed	using	the	transaortic	approach.	A	37‐year‐old	male	patient	
(No.	4)	who	had	undergone	MVR	was	referred	for	WPW	syndrome.3 
In	an	electrophysiological	study,	AVRT	using	manifest	AP	at	the	dis‐
tal	CS	was	induced.	RFCA	through	the	transseptal	approach	was	not	
successful.	The	AP	at	the	proximal	vein	of	Marshall	was	successfully	
ablated	through	the	CS.	A	50‐year‐old	female	patient	(No.	5)	who	had	
undergone	MVR	with	a	bileaflet	mechanical	valve	developed	narrow	
QRS	tachycardia	involving	a	left	lateral	AP.	RFCA	through	the	transsep‐
tal,	transaortic,	and	CS	approaches	failed.	A	30‐year‐old	male	patient	
(No.	6)	who	had	undergone	MVr	with	an	annuloplasty	ring	developed	
narrow	QRS	tachycardia	involving	a	manifest	posteroseptal	AP,	RFCA	
through	the	right	septal,	transseptal,	and	CS	approaches	failed.
3.3 | Catheter approaches and RFCA techniques 
used for APs at the site of prior tricuspid VS
Radiofrequency	catheter	ablation	of	APs	at	 the	site	of	prior	 tricus‐
pid	VS	was	successful	 in	all	 three	patients	 (Table	2).	 In	 these	 three	
F I G U R E  2  Radiofrequency	catheter	
ablation	(RFCA)	using	the	bipolar	ablation	
technique	in	a	patient	with	left	posterior	
accessory	pathway	who	underwent	
mitral	valve	replacement	with	a	bileaflet	
mechanical	valve.	Fluoroscopic	images	
of	the	RFCA	site	in	the	right	(A)	and	
left	(B)	anterior	oblique	views.	The	
ablation	catheter	(a)	was	placed	under	
the	mechanical	valve,	and	the	dispersive	
catheter	(d)	was	placed	in	the	coronary	
sinus.	C,	Intracardiac	electrogram	
during	RFCA	for	the	accessory	pathway.	
Ventricular	signals	(arrow	with	solid	line)	
with	far‐field	atrial	signals	are	observed	
at	the	ablation	catheter	(ABL	d)	and	the	
atrial	signals	(arrow	with	dotted	line)	are	
observed	at	the	dispersive	catheter	 
(DISP	d)
(A)
(C)
(B)
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patients,	who	had	Ebstein	anomaly	and	WPW	syndrome,	delta	waves	
were	 detected	 on	 post‐TVR	 ECG;	moreover,	 all	 three	 patients	 had	
APs	with	 slow	 and	 decremental	 conduction.	 The	 trans‐prosthetics	
and	above‐prosthetics	approaches	were	used	in	two	and	one	patient,	
respectively.	We	further	provide	an	overview	of	these	three	cases.
A	23‐year‐old	male	patient	(No.	7)	with	WPW	syndrome	had	un‐
dergone	TVR	with	a	bileaflet	mechanical	valve	for	Ebstein	anomaly.	
ECG	showed	no	delta	wave	before	surgery.	Just	after	surgery,	narrow	
QRS	tachycardia	and	a	delta	wave	were	noted.	RFCA	for	right	pos‐
terior	AP	was	attempted	four	times	before	the	patient	was	referred	
to	our	hospital.	RFCA	 failed	on	 the	 first	 three	 attempts.	Upon	 the	
fourth	attempt,	RFCA	was	successful	but	the	AP	recurred.	The	fifth	
electrophysiological	 study	 revealed	 antidromic	 AVRT	 involving	 a	
right	posterior	AP	with	slow	and	decremental	conduction	property.	
Right	coronary	angiogram	findings	confirmed	that	the	true	tricuspid	
annulus	was	located	under	the	mechanical	valve.	After	the	irrigated	
F I G U R E  3  Radiofrequency	catheter	
ablation	(RFCA)	with	the	trans‐prosthetics	
approach	in	a	patient	with	right	posterior	
accessory	pathway	who	underwent	
tricuspid	valve	replacement	with	a	
bileaflet	mechanical	valve.	Fluoroscopic	
images	of	the	RFCA	site	(*)	in	the	right	
(A)	and	left	(B)	anterior	oblique	views.	C,	
Intracardiac	electrogram	during	RFCA	
for	the	accessory	pathway.	The	earliest	
ventricular	signals	(arrow)	at	the	ablation	
catheter	(ABL	d)	are	observed	during	
antidromic atrioventricular reentrant 
tachycardia
(A)
(C)
(B)
F I G U R E  4  Suggested	stepwise	approach	to	radiofrequency	catheter	ablation	of	accessory	pathways	at	the	site	of	prior	valve	surgery.	
Approach	to	the	site	of	mitral	(A)	and	tricuspid	(B)	valve	surgery.	AP,	accessory	pathway;	CS,	coronary	sinus
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ablation	 catheter	was	meticulously	 passed	 through	 the	mechanical	
valve	 under	 fluoroscopic	 guidance,	 RFCA	 for	 the	 AP	was	 success‐
fully	 performed	 (trans‐prosthetics	 approach;	 Figure	 3).	 Following	
RFCA,	no	change	regarding	the	motion	of	the	mechanical	valve	was	
noted.	A	26‐year‐old	female	patient	(No.	8)	had	undergone	TVR	with	
a	bioprosthetic	valve	for	Ebstein	anomaly.4	She	had	no	evidence	of	
preexcitation	 before	 and	 after	 surgery.	 She	 presented	 palpitation	
and	syncope.	 In	an	electrophysiological	 study,	antidromic	AVRT	 in‐
volving	a	right	posterolateral	AP	with	slow	and	decremental	conduc‐
tion	property	was	 induced.	Mapping	above	 the	bioprosthetic	valve	
showed	no	ideal	target	site.	RFCA	for	AP	was	successfully	performed	
under	the	bioprosthetic	valve	using	the	trans‐prosthetics	approach.	
A	15‐year‐old	female	patient	(No.	9)	had	undergone	TVR	with	a	bio‐
prosthetic	valve	for	Ebstein	anomaly.5	ECG	showed	no	preexcitation	
before	surgery.	Six	years	later,	the	patient	presented	paroxysmal	su‐
praventricular	tachycardia	and	delta	waves	were	noted	on	ECG.	An	
electrophysiological	study	revealed	ortho‐	and	antidromic	AVRT	in‐
volving	a	right	posterolateral	AP	with	decremental	conduction	prop‐
erty.	The	AP	was	successfully	ablated	above	the	bioprosthetic	valve.
4  | DISCUSSION
4.1 | Overview of findings
The	main	findings	of	this	retrospective	study	were	that:	 (a)	APs	at	
the	site	of	prior	TVR	for	Ebstein	anomaly	had	decremental	conduc‐
tion	property;	(b)	the	transaortic	approach,	CS	approach,	and	bipolar	
ablation	 technique	 using	 the	 transaortic	 and	CS	 approaches	were	
occasionally	effective	in	RFCA	for	APs	at	the	site	of	mitral	VS;	(c)	the	
transseptal	approach	was	not	effective;	and	(d)	the	trans‐prosthetics	
approach	was	effective	in	RFCA	for	APs	at	the	site	of	tricuspid	VS.
4.2 | Challenges in RFCA of APs at the site of 
prior VS
It	 is	 challenging	 to	 perform	RFCA	 for	APs	 at	 the	 site	 of	 prior	VS.	
Several	 aspects	 contribute	 to	 this	 difficulty.	 First,	 the	 prosthetic	
valve	or	annuloplasty	ring	 impedes	the	catheter	approach	and	de‐
livery	of	radiofrequency	energy	to	the	APs.	It	is	because	the	sewing	
ring	of	 the	prosthetic	valve	or	annuloplasty	 ring	was	sutured	with	
the	 annulus.6	 Second,	 there	 is	 severe	 fibrosis	 around	 the	 annulus	
owing	to	the	prior	VS,	which	may	obscure	AP	signals	and	impede	de‐
livery	of	radiofrequency	energy.7	Therefore,	detailed	mapping	of	the	
areas	both	above	and	below	the	prosthetic	valve	is	an	essential	step.
4.3 | Prevalence of APs with decremental 
conduction property
The	prevalence	of	APs	with	decremental	conduction	property	is	re‐
ported	at	7.6%‐9.7%	in	patients	without	structural	heart	disease.8,9 
The	 prevalence	 of	 decremental	 conduction	 APs	 among	 patients	
with	Ebstein	anomaly	 is	comparable	 to	 that	noted	among	patients	
with	structurally	normal	heart.10	However,	decremental	conduction	
APs	are	more	frequent	in	patients	with	persistent	left	superior	vena	
cava.11,12	 In	 the	present	 study,	 the	prevalence	of	APs	with	 decre‐
mental	conduction	property	was	high	in	patients	with	AP	at	the	site	
of	prior	VS.	In	particular,	all	three	patients	who	had	undergone	TVR	
for	Ebstein	anomaly	exhibited	APs	with	slow	and	decremental	con‐
duction	property.	Although	the	reason	for	decremental	conduction	
is	unclear,	two	possible	explanations	can	be	suggested.	(a)	APs	with‐
out	decremental	conduction	property	might	a	have	higher	probabil‐
ity	of	overt	delta	wave	and	performing	RFCA	before	VS	 than	APs	
with	 decremental	 conduction	 property.	 Because	 delta	 waves	 are	
not	always	noted	on	presurgery	ECG	 in	patients	with	APs	exhibit‐
ing	slow	and	decremental	conduction,	not	all	such	patients	might	be	
indicated	for	RFCA	before	VS.	This	explanation	was	our	guess	based	
on	 the	cases	 in	 the	present	 study.	 (b)	APs	might	be	partially	dam‐
aged	either	by	the	surgery	itself	or	by	prior	RFCA	attempts	and	show	
decremental	 conduction	 property.13‒15	 The	 slow	 and	 decremental	
conduction	properties	 could	 contribute	 to	minimal	or	 intermittent	
ventricular	preexcitation,	leading	to	difficulties	in	diagnosing	WPW	
syndrome	and	mapping	these	APs	in	an	electrophysiological	study.	
Thus,	slow	and	decremental	conduction	property	may	be	the	reason	
why	none	of	the	three	patients	in	this	study	who	had	APs	at	the	site	
of	prior	TVR	exhibited	preexcitation	on	preoperative	ECG.
4.4 | Transaortic approach
Mapping	 of	 the	 areas	 both	 above	 and	below	 the	 prosthetic	mitral	
valve	 can	 be	 performed	 using	 the	 transseptal	 and	 transaortic	 ap‐
proaches.	For	RFCA	of	APs	at	 the	site	of	mitral	VS	 (six	cases),	 the	
transaortic	 approach	 was	 successful	 in	 two	 patients	 but	 failed	 in	
another	 two	 patients,	 whereas	 the	 transseptal	 approach	 failed	 in	
all	five	patients	in	whom	it	was	attempted.	The	position	of	the	me‐
chanical	mitral	valve	may	account	for	this	discrepancy	in	success	rate.	
Specially,	the	transaortic	approach	might	be	effective	if	the	mechani‐
cal	valve	is	located	slightly	toward	the	atrial	side,	but	not	if	the	me‐
chanical	valve	is	located	at	the	true	mitral	annulus.	In	patients	with	
a	relatively	small	mitral	valve	annulus,	cardiac	surgeons	occasionally	
implant	the	mechanical	valve	slightly	on	the	atrial	side	from	the	mitral	
valve	annulus.	Because	it	is	difficult	to	determine	the	exact	position	
of	 the	mechanical	valve	based	on	 imaging	alone,	 it	 is	 important	 to	
map	the	areas	both	above	and	below	the	mechanical	valve.
4.5 | Trans‐prosthetics approach
The	 above‐	 and	 trans‐prosthetics	 approach	 facilitated	 detailed	
mapping	 of	 areas	 above	 and	 below	 the	 prosthetic	 tricuspid	 valve.	
Generally,	 it	 is	 safe	 that	 the	catheter	 is	passed	 through	a	biopros‐
thetic	valve	with	particular	care.4	It	is	not	recommended	to	pass	the	
catheter	through	the	mechanical	valve,	as	doing	so	carries	a	risk	of	
catheter	entrapment,	mechanical	valve	damage,	and	acute	regurgita‐
tion	through	the	mechanical	valve.	However,	this	recommendation	is	
based	mainly	on	reports	of	cases	involving	caged‐ball	or	tilting‐disc	
valves.16‒18	In	our	patients,	the	ablation	catheter	was	passed	through	
the	bileaflet	mechanical	tricuspid	valve	by	carefully	manipulating	the	
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catheter	under	fluoroscopic	guidance.	There	were	no	complications	
and	 it	was	 feasible	 to	 retain	 the	 ablation	 catheter	 across	 the	me‐
chanical	valve	for	about	10‐15	minutes.
In	Ebstein	anomaly,	the	tricuspid	annulus	is	separated	into	the	true	
(or	anatomic)	annulus	and	the	functional	annulus,	which	is	displaced	
downward.19,20	During	TVR	for	Ebstein	anomaly,	the	prosthetic	valve	
is	usually	implanted	on	the	atrial	side	to	avoid	injury	to	the	conduc‐
tion	system.20,21	In	patients	with	Ebstein	anomaly,	the	right	APs	can	
be	 successfully	 ablated	 at	 the	 true	 annulus.10	 Therefore,	 to	 ensure	
successful	 RFCA	 for	 right	 APs	 in	 patients	with	 Ebstein	 anomaly,	 it	
is	necessary	to	accurately	map	the	area	below	the	prosthetic	valve.	
Right	coronary	angiography	is	helpful	for	recognizing	the	location	of	
the	true	tricuspid	annulus	because	the	right	coronary	artery	demar‐
cates	this	landmark.21	The	exact	lateral	view	of	the	mechanical	valve	
leaflets	is	suitable	for	fluoroscopic	guidance	of	the	trans‐prosthetics	
approach	because	 this	view	provides	helpful	 information	about	 the	
location	of	leaflet	hinges,	as	well	as	leaflet	motion.
4.6 | Bipolar ablation technique
Ensuring	 effective	 radiofrequency	 energy	 delivery	 to	 the	 AP	 is	
critical	 because	 the	 prosthetic	 components	 and	 fibrotic	 tissue	
around	the	annulus	hinder	energy	delivery.	Using	the	bipolar	ab‐
lation	 technique,	 a	 deep	 and	 transmural	 ablation	 lesion	 can	 be	
created.22‒24	In	our	patients,	the	second	ablation	catheter,	which	
served	 as	 a	 dispersive	 electrode,	was	 connected	 to	 the	port	 for	
the	dispersive	patch	of	 the	 radiofrequency	generator	and	 to	 the	
ECG	recording	system	using	a	custom‐made	cable	(Figure	S1).	To	
apply	the	bipolar	ablation	technique	for	RFCA	of	left	APs,	the	abla‐
tion	catheter	should	be	placed	under	the	mechanical	mitral	valve	
via	 the	 transaortic	 approach,	 whereas	 the	 dispersive	 catheter	
should	be	placed	in	the	CS.	This	setup	with	the	ablation	catheter	
at	the	ventricular	endocardial	area	and	the	dispersive	catheter	at	
the	atrial	epicardial	area	facilitates	ablation	of	the	AP	because	the	
AP	is	located	between	the	ablation	catheter	and	dispersive	cath‐
eter.	Ablation	can	be	started	at	 low	power	(10	W),	followed	by	a	
gradual	increase	up	to	30	W	with	impedance	monitoring	to	avoid	
steam	pop,	which	is	more	likely	to	occur	at	a	power	of	≥30	W.23,25 
Damage to the left circumflex coronary artery can occur when 
RFCA	 is	 performed	 around	 the	CS.26,27	 Therefore,	 particular	 at‐
tention	should	be	paid	to	any	symptom	of	chest	pain	and	to	signs	
of	ST	segment	deviation	on	ECG	monitoring.
4.7 | Stepwise approach to APs at the site of 
prior VS
Based	on	the	success	rate	and	accessibility,	we	suggest	a	stepwise	
approach	to	RFCA	of	APs	at	the	site	of	prior	mitral	or	tricuspid	VS.	In	
patients	with	prior	mitral	VS,	we	recommend	the	following	strategy:	
transaortic	 approach	→	 transseptal	 approach	→	 CS	 approach	→	 
bipolar	 ablation	 (an	 ablation	 catheter	 below	 the	 prosthetic	 valve	
via	 the	 transaortic	 approach	 and	 a	 dispersive	 catheter	 in	 the	
CS)	→	surgical	ablation	(Figure	4A).	In	patients	with	prior	tricuspid	
VS,	 we	 recommend	 the	 following	 strategy:	 above‐prosthetics	 ap‐
proach	→	 trans‐prosthetics	 approach	→	bipolar	 ablation	 (ablation	
catheter	below	the	prosthetic	valve	and	dispersive	catheter	above	
the	prosthetic	valve)	→	surgical	ablation	(Figure	4B).
4.8 | Study limitations
The	number	of	patients	 in	 the	present	 study	was	 small	because	 the	
prevalence	of	AP	among	patients	with	prior	mitral	or	 tricuspid	VS	 is	
generally	very	low.	Furthermore,	there	were	insufficient	data	regard‐
ing	the	patients	described	in	previously	published	case	reports	and	in‐
cluded	in	the	present	study	(historical‐VS	subgroup),	and	we	could	not	
exclude	publication	bias.	Moreover,	 because	 case	 reports	 describing	
failed	procedures	and	patients	with	recurrence	or	complications	may	be	
less	likely	be	published,	we	could	not	conduct	between‐group	compari‐
sons	of	the	success,	recurrence,	and	complication	rates.	Additionally,	
we	 could	 not	 validate	 the	 safety	 of	 passing	 the	 catheter	 across	 the	
mechanical	mitral	 or	 aortic	 valve.	 As	 our	 patients	 only	 had	 bileaflet	
valves,	we	were	not	able	 to	suggest	useful	catheter	approaches	and	
RFCA	techniques	for	RFCA	of	APs	adjacent	to	mechanical	valves	with	
caged‐ball	or	tilting‐disc	design.	Finally,	we	could	not	validate	the	ef‐
ficacy	of	the	bipolar	ablation	techniques	for	right	APs	in	patients	who	
underwent	TVR.	Further	studies	are	needed	to	clarify	the	efficacy	and	
safety	of	the	stepwise	approach	for	APs	at	the	site	of	prior	VS.
5  | CONCLUSIONS
To	achieve	successful	RFCA	of	APs	at	the	site	of	prior	VS,	it	is	impor‐
tant	to	conduct	detailed	mapping	of	the	areas	both	above	and	below	
the	prosthetic	valve,	as	well	as	to	ensure	effective	radiofrequency	en‐
ergy	delivery	using	various	catheter	approaches	and	RFCA	techniques.
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